Global marketing of microbiome products expanded
Hennigsdorf b. Berlin, 26 May 2021 – BELANO medical AG will expand its health care activities as well as European and global sales and marketing of microbiome-based products. Therefore, the supervisory board decided to expand the company’s management board by a position for marketing and sales, and appointed Alexander Welsch to the board to handle this new responsibility. Currently, the 48-year-old is chief executive at SIRIUS GmbH für kosmetische und pharmazeutische Produkte, a Dr. KADE Health Care company. He will start his new position on 1 June.
“Alexander Welsch contributed to the successful launching of familiar brands such as Anti-Brumm, Lefax, and DOC pain relief gel where he showcased his expertise, experience, and creativity”, explains Renke Lührs, Chairman of BELANO medical AG’s supervisory board. He was well-respected in the industry, a result of more than 20 years of executive experience in sales and marketing positions for NEM, OTC, and dermatological cosmetics, as well as the significant sales increases achieved for widely-known brand-name products. “We rely on his widely-ranging experience and his network to market our medical skincare and other microbiome products globally and to continue building the BELANO medical brand”, Lührs continues.
Alexander Welsch began his career at Bayer Vital Consumer Care GmbH before moving into marketing at Klosterfrau GmbH in Cologne. As head of marketing, he went to Hermes Arzneimittel GmbH and later became chief executive at Dr. B. Scheffler GmbH, head of pharmaceutical marketing and sales at Krüger GmbH, as well as chief executive of Vendus Business Partner GmbH.
BELANO medical AG holds a number of patents on microbiotic (microbial) agents which are used in its own medical skincare products as well as in private label health care products of partners such as Henkel AG and the Müller chain of retail stores. By issuing a convertible bond (WKN: A3H2UW; ISIN: DE000A3H2UW2) at the end of last year, BELANO medical established the financial basis for further building its business.
About BELANO medical AG:
BELANO medical AG is a biotechnology company which leverages the findings of its research into beneficial microorganisms for pharmaceutical and care products. The company develops and brings to market novel approaches to medical skin care, disease prevention, and the support of healing processes with the aim of creating new therapeutic options for diseases and indications which currently cannot be treated satisfactorily. BELANO’s mission is to make its patented agents and products available to everyone. To do so, the company relies on national and international collaborations with distributors and larger partners such as Henkel AG or the Müller chain of retail stores.